Published in Science on January 25, 1991
The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol (1992) 1.36
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A (1996) 1.31
Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc Natl Acad Sci U S A (1991) 1.23
A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Br J Pharmacol (1992) 0.96
Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist. Br J Pharmacol (1992) 0.96
Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists. Br J Pharmacol (1993) 0.95
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Br J Pharmacol (1992) 0.92
Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions. Br J Clin Pharmacol (2014) 0.91
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci (2004) 0.90
Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/-)-CP-96,345 in neurones cultured from rat cortex. Br J Pharmacol (1993) 0.90
Peptone stimulates CCK-releasing peptide secretion by activating intestinal submucosal cholinergic neurons. J Clin Invest (1996) 0.88
Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur J Pharmacol (2004) 0.84
Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum. Br J Pharmacol (1994) 0.76
The role of substance P in depression: therapeutic implications. Dialogues Clin Neurosci (2002) 0.75
Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies. Br J Pharmacol (1992) 0.75
A potent nonpeptide antagonist of the substance P (NK1) receptor. Science (1991) 4.06
Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res (1984) 2.21
Hebbian synapses in hippocampus. Proc Natl Acad Sci U S A (1986) 2.16
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther (1995) 1.57
Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu Rev Neurosci (1988) 1.53
Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res (1983) 1.51
The scope of unmet maternal health needs in pediatric settings. Pediatrics (1999) 1.46
Studies on rabbit lymphocytes in vitro. XI. Superaddition of anti-allotypic lymphocyte transformation: evidence for multipotent lymphoid cells. J Immunol (1970) 1.32
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A (1996) 1.31
Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl) (1996) 1.29
Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. J Pharmacol Exp Ther (1995) 1.28
Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther (1993) 1.26
Humoral and cellular aspects of immunoglobulin allotype suppression in the rabbit. I. Kinetics of neutralization of suppression. Immunology (1973) 1.25
Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. Nature (1993) 1.21
Biological monitoring of agricultural workers exposed to pesticides: I. Cholinesterase activity determinations. J Occup Med (1986) 1.20
Immunogenic and antigenic epitopes of immunoglobulins--V. Reactivity of a panel of monoclonal antibodies with sub-fragments of human Fc gamma and abnormal paraproteins having deletions. Mol Immunol (1983) 1.15
CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther (1998) 1.12
Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus. J Physiol (1986) 1.09
2-Amino-4-phosphonobutyrate selectively blocks mossy fiber-CA3 responses in guinea pig but not rat hippocampus. Brain Res (1984) 1.09
Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J Biol Chem (1980) 1.08
Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus. J Pharmacol Exp Ther (1986) 1.06
The neuronal growth-associated protein GAP-43 interacts with rabaptin-5 and participates in endocytosis. J Neurosci (1998) 1.04
Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist. Neuropharmacology (2002) 1.03
The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels. Eur J Pharmacol (1992) 1.02
Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res (1983) 1.01
Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol (1995) 1.00
Activity of serotonin-containing neurons in the nucleus raphe pallidus of freely moving cats. Brain Res (1982) 0.99
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem (1996) 0.97
Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther (1996) 0.97
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists. Bioorg Med Chem Lett (2001) 0.97
Mechanism of allotype suppression in the rabbit. Transplant Rev (1975) 0.95
Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. Eur J Pharmacol (1992) 0.95
The activity of homologous and heterologous anti-allotypic sera in transformation and allotypic suppression in rabbits. Immunology (1972) 0.94
Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin. J Biol Chem (1978) 0.93
Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats. Proc Natl Acad Sci U S A (1991) 0.92
Response of dopaminergic neurons in cat to auditory stimuli presented across the sleep-waking cycle. Brain Res (1983) 0.92
Modulation of hippocampal theta oscillation by histamine H3 receptors. J Pharmacol Exp Ther (2007) 0.92
Need we revive falling autopsy rates? Time trends in PAS hospitals in the United States. PAS Rep (1977) 0.92
Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J Biol Chem (1993) 0.91
Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus. Brain Res (1986) 0.91
Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands. J Biol Chem (1997) 0.91
Humoral and cellular aspects of immunoglobulin allotype suppression in the rabbit. II. Effect of beta locus suppression on immunoglobulin receptor-bearing lymphocytes. Immunology (1974) 0.90
Raphe unit activity in freely moving cats: effects of phasic auditory and visual stimuli. Brain Res (1982) 0.89
Biological monitoring of agricultural workers exposed to pesticides: II. Monitoring of intact pesticides and their metabolites. J Occup Med (1986) 0.89
Immunogenic and antigenic epitopes of immunoglobulins--VII. The topographical distribution of Fc gamma epitopes and the relationship of an iso-allotypic specificity to the presence of histidine 435. Mol Immunol (1984) 0.89
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst. J Med Chem (1992) 0.89
Activity of serotonin-containing neurons in nucleus centralis superior of freely moving cats. Exp Neurol (1984) 0.87
In vivo autoradiography: visualization of stress-induced changes in opiate receptor occupancy in the rat brain. Brain Res (1984) 0.86
Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist. Mol Pharmacol (1996) 0.86
Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Proc Natl Acad Sci U S A (1993) 0.85
Predictions of extreme precipitation and sea-level rise under climate change. Philos Trans A Math Phys Eng Sci (2002) 0.85
Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology (Berl) (1982) 0.85
Parallel antagonism of synaptic transmission and kainate/quisqualate responses in the hippocampus by piperazine-2,3-dicarboxylic acid analogs. J Neurosci (1986) 0.85
Characterization of end-plate conductance in transected frog muscle: modification by drugs. J Pharmacol Exp Ther (1981) 0.85
The concentration of creatine in meat, offal and commercial dog food. Res Vet Sci (1997) 0.84
Humoral and cellular aspects of immunologlobulin allotype suppression in the rabbit. III. Production of anti-allotypic antibody by suppressed animals. Immunology (1975) 0.83
Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodies. Immunology (1986) 0.83
PASport. Use of Professional Activity Study (PAS) data to focus medical care evaluation studies. QRB Qual Rev Bull (1977) 0.83
Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists. J Med Chem (1990) 0.83
Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected]. J Biol Chem (1994) 0.82
Studies on rabbit lymphocytes in vitro. XVI. Restimulation of antiallotypically stimulated and blocked cultures. J Immunol (1973) 0.82
Ketamine and ditran block end-plate ion conductance and [3H]phencyclidine binding to electric organ membrane. J Pharmacol Exp Ther (1982) 0.82
Dimensional stability of composite used as a core material. J Prosthet Dent (1986) 0.82
Single unit activity of dopaminergic neurons in freely moving cuts. Life Sci (1981) 0.81
Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain. Eur J Pharmacol (1989) 0.81
Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo. Neuropsychopharmacology (1996) 0.80
Chloral hydrate anesthesia alters the responsiveness of central serotonergic neurons in the cat. Brain Res (1984) 0.80
Hematology and clinical chemistry parameters in the cat (Felis domesticus). J Nutr (1998) 0.80
Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation. Neuropsychopharmacology (1999) 0.80
Antagonism of lateral olfactory tract synaptic potentials in rat prepyriform cortex slices. Brain Res (1986) 0.80
Acidic amino acid antagonists of lateral perforant path synaptic transmission: agonist-antagonist interactions in the dentate gyrus. Neurosci Lett (1982) 0.79
CP-96,345 antagonism of NK1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effects. Eur J Pharmacol (1992) 0.79
CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor. Regul Pept (1993) 0.79
Raphe unit activity in freely moving cats is altered by manipulations of central but not peripheral motor systems. Brain Res (1983) 0.79
Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation. Biol Psychiatry (1983) 0.79
In vivo opioid receptor occupation in the rat brain following exercise. Med Sci Sports Exerc (1986) 0.79
Aromatic thiazole derivatives: structurally novel and selective serotonin-3 receptor antagonists. J Med Chem (1990) 0.79
Studies on rabbit lymphocytes in vitro. XV. The effect of blocking serum on anti-allotypic lymphocyte transformation. J Immunol (1972) 0.78
Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates. J Immunol Methods (1985) 0.78
Selective inhibition of the carotid body sensory response to hypoxia by the substance P receptor antagonist CP-96,345. Proc Natl Acad Sci U S A (1993) 0.78
Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor. Regul Pept (1993) 0.78
Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats. Brain Res (1981) 0.78
Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studies. Nucl Med Biol (1993) 0.78
Transfusion reactions in donor-specific blood transfusion patients resulting from transfused maternal antibody. Transplantation (1984) 0.78
Film thickness measurements of a paint-on die spacer. J Prosthet Dent (1988) 0.78
Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog. J Pharmacol Exp Ther (1997) 0.78
5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonists. J Med Chem (1994) 0.78
Atypical antipsychotics--recent findings and new perspectives. Med Res Rev (1989) 0.77
Dimensional stability of silver amalgam and composite used as core materials. J Prosthet Dent (1987) 0.77
Discovery of CP-96,345 and its characterization in disease models involving substance P. Regul Pept (1993) 0.77
Arylamine spider toxins antagonize NMDA receptor-mediated synaptic transmission in rat hippocampal slices. Synapse (1991) 0.77